Sort
15,842 grants matching “pancreatic cancer”
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis - Diversity Supplement
$79,090Robert Singhung Banh · New York University School Of Medicine · R37 · FY2024 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$79,063Sita Kugel · Fred Hutchinson Cancer Center · R37 · FY2021 · CA
Medical History, Medications, and Pancreatic Cancer Risk
$79,000Group Health Cooperative · R03 · FY2004 · CA
A novel combination approach for pancreatic cancer prevention
$79,000Gerardo Guillermo Mackenzie · State University New York Stony Brook · R03 · FY2015 · CA
Molecular Basis for Localization and Activation of Focal Adhesion Kinase
$79,000Stefan T Arold · University Of Tx Md Anderson Can Ctr · R03 · FY2012 · CA
Parental age at birth and risk of adult-onset cancer in female offspring
$78,960Yani Lu · Beckman Research Institute/City Of Hope · R03 · FY2013 · CA
Exploiting gold nanoparticle as a probe to identify therapeutic targets
$78,953Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Programming of beta-cells and Glucose Homeostasis by Maternal Metformin Exposure
$78,917Brigid Ellen Gregg · University Of Michigan At Ann Arbor · K08 · FY2021 · DK
Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
$78,890Peter Qinhua Huang · Kalyra Pharmaceuticals, Inc. · R44 · FY2018 · CA
Pancreatic cystic lesions: descriptive epidemiology and natural history
$78,875Paige M. Bracci · University Of California, San Francisco · R03 · FY2014 · CA
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
$78,850Mark A. Mc Niven · Mayo Clinic Rochester · R03 · FY2011 · CA
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
$78,850Mark A. Mc Niven · Mayo Clinic Rochester · R03 · FY2012 · CA
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$78,847Clifford Cho · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
$78,781Behnam Nabet · Fred Hutchinson Cancer Center · K22 · FY2021 · CA
Targeting tumor-stromal interaction for pancreatic cancer therapy
$78,765Ajay Pratap Singh · University Of South Alabama · R01 · FY2016 · CA
Evaluation of the antitumorigenic roles of miR-122 in pancreatic cancer
$78,750Rajgopal Govindarajan · Ohio State University · R03 · FY2022 · CA
Evaluation of the antitumorigenic roles of miR-122 in pancreatic cancer
$78,750Rajgopal Govindarajan · Ohio State University · R03 · FY2023 · CA
Understanding the link between high-fructose intake and pancreatic cancer development
$78,750Jelena Todoric · University Of California, San Diego · R03 · FY2020 · CA
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$78,750Richard L. Klemke · University Of California, San Diego · R01 · FY2019 · CA
Understanding the link between high-fructose intake and pancreatic cancer development
$78,604Jelena Todoric · University Of California, San Diego · R03 · FY2019 · CA
Developmental Research Program
$78,515Michael G Brattain · University Of Nebraska Medical Center · P50 · FY2011 · CA
Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors
$78,500Robert R. Alfano · City College Of New York · R03 · FY2017 · CA
Evaluating the impact of KRas codon bias on pancreatic cancer
$78,500Christopher M Counter · Duke University · R03 · FY2012 · CA
Class III PI3K as an Autophagy Reactivation Switch in Malignant Transformation
$78,343Lindsey N Young · University Of California, San Diego · K00 · FY2022 · CA
Community Outreach Core
$78,244Sandra G Suther · Florida Agricultural And Mechanical Univ · U54 · FY2024 · CA